Centene Reports Q3 2026 Loss of $0.14 per Share, Adjusted EPS of $0.58

What happened

Centene reported a third-quarter 2026 GAAP diluted loss of $0.14 per share and adjusted diluted earnings of $0.58 per share. Total revenue was $50.647 billion and net loss was $71 million, while the company raised its 2026 adjusted EPS guidance floor above $5.20.

Confirmed

Global impact / market context

Centene's revenue rose slightly and its loss shrank sharply from a year earlier, which suggests costs are becoming more manageable. Higher profit guidance can support investor confidence, but falling membership in Medicaid and Marketplace plans may pressure future premium revenue.

Analyst inference

Centene is a health insurer whose results reflect enrollment trends and medical cost levels. Membership fell to 25.7 million from 28.0 million, with Marketplace dropping to 3.4 million from 5.8 million, which shifts the mix toward Medicare plans.

Analyst inference

What to watch

1. The health benefits ratio was 92.7%, which means medical costs consumed most of premium revenue, leaving a thin profit per sale. The adjusted SG&A expense ratio was 6.5%, covering administrative costs. Confirmed
2. Investors could compare future quarters to see whether the raised 2026 adjusted EPS floor above $5.20 holds as membership declines, since fewer members may reduce premium revenue and spread fixed costs over a smaller base. Proposed
3. Medicaid and Marketplace performance remains uncertain because the article text ends mid-sentence. Continued membership losses there could offset Medicare Advantage and PDP strength, affecting revenue and profit per sale. Analyst inference

Evidence

• Original source link unavailable